losartan has been researched along with Mucositis in 1 studies
Losartan: An antagonist of ANGIOTENSIN TYPE 1 RECEPTOR with antihypertensive activity due to the reduced pressor effect of ANGIOTENSIN II.
losartan : A biphenylyltetrazole where a 1,1'-biphenyl group is attached at the 5-position and has an additional trisubstituted imidazol-1-ylmethyl group at the 4'-position
Mucositis: An INFLAMMATION of the MUCOSA with burning or tingling sensation. It is characterized by atrophy of the squamous EPITHELIUM, vascular damage, inflammatory infiltration, and ulceration. It usually occurs at the mucous lining of the MOUTH, the GASTROINTESTINAL TRACT or the airway due to chemical irritations, CHEMOTHERAPY, or radiation therapy (RADIOTHERAPY).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Intestinal mucositis (IM) is a common side effect of 5-fluorouracil (5-FU)-based chemotherapy, which negatively impacts therapeutic outcomes and delays subsequent cycles of chemotherapy resulting in dose reductions and treatment discontinuation." | 8.02 | Losartan improves intestinal mucositis induced by 5-fluorouracil in mice. ( Barra, PB; da Silva Martins Rebouças, C; de Araújo, AA; de Carvalho Leitão, RF; de Castro Brito, GA; de Medeiros, CACX; de Sales Mota, PCM; Figueiredo, JG; Guerra, GCB; Marques, VB; Oliveira, MMB; Ribeiro, SB, 2021) |
| "Intestinal mucositis (IM) is a common side effect of 5-fluorouracil (5-FU)-based chemotherapy, which negatively impacts therapeutic outcomes and delays subsequent cycles of chemotherapy resulting in dose reductions and treatment discontinuation." | 4.02 | Losartan improves intestinal mucositis induced by 5-fluorouracil in mice. ( Barra, PB; da Silva Martins Rebouças, C; de Araújo, AA; de Carvalho Leitão, RF; de Castro Brito, GA; de Medeiros, CACX; de Sales Mota, PCM; Figueiredo, JG; Guerra, GCB; Marques, VB; Oliveira, MMB; Ribeiro, SB, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Oliveira, MMB | 1 |
| de Araújo, AA | 1 |
| Ribeiro, SB | 1 |
| de Sales Mota, PCM | 1 |
| Marques, VB | 1 |
| da Silva Martins Rebouças, C | 1 |
| Figueiredo, JG | 1 |
| Barra, PB | 1 |
| de Castro Brito, GA | 1 |
| de Carvalho Leitão, RF | 1 |
| Guerra, GCB | 1 |
| de Medeiros, CACX | 1 |
1 other study available for losartan and Mucositis
| Article | Year |
|---|---|
Losartan improves intestinal mucositis induced by 5-fluorouracil in mice.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Antimetabolites, Antineoplastic; Cytokines; Female | 2021 |